This invention provides estrogen receptor modulators of formula I, having the structure ##STR00001## wherein R.sub.1, R.sub.2, R.sub.2a, R.sub.3, R.sub.3a, and R.sub.4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Pharmaceutical/cosmetic compositions comprising a novel RARbeta receptor-activating ligand

> Method for augmenting the effects of serotonin reuptake inhibitors

> Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
~ 00517